Where are you?
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Singapore
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.
You are viewing as from Change

Liontrust China Fund

Q4 2023 review

Past performance does not predict future returns. You may get back less than you originally invested. Reference to specific securities is not intended as a recommendation to purchase or sell any investment.

The Liontrust China Fund returned -10.6% over the quarter, versus the IA China/Greater China sector average of -8.5% and -8.3% from the MSCI China Index (both comparator benchmarks)*^.

 

The China market continued to trend down this quarter. This was due to concerns remaining around the stability of the property sector, as well as a slow consumer recovery and weak economic data. A sharp step down also occurred at the end of the year following a surprise regulatory announcement on the gaming sector which outlined spending limits for users. This hit sentiment as fears of further harsh regulation resurfaced. However, the government quickly issued reassuring statements of support for the industry which allowed the affected stocks to stage a strong rebound.

The Liontrust China Fund returned -10.6% in the quarter. The portfolio was impacted by the gaming regulation announcement and positions the consumer discretionary sector were also impacted by weak consumer sentiment. Wuxi Bio, a company in the healthcare sector also released disappointing guidance for the coming year. This was somewhat balanced by outperformance of our positions in Taiwan, particularly MediaTek, which benefitted from increased earnings estimates after strong feedback on its AI enabled chips.

This quarter, we initiated a position in an e-commerce platform with strong growth overseas as well as a very competitive domestic position due to their foothold in value for money e-commerce. This was paid for with a reduction in other consumer discretionary positions as well as a reduction in the financials sector. We also initiated a position in a Chinese online travel company as domestic travel is recovering well post-Covid with a promising outlook for the coming year.

Going forward, a constructive case can be made looking at depressed valuations with a key trigger being prompt and robust easing from policymakers to help rebuild confidence and recharge the economy. The annual parliamentary meeting in March should give an idea of how the government sees the economy progressing and what stimulus measures might be enacted. A clear stabilisation of US and China geopolitical tensions would also provide further support; the upcoming elections in Taiwan, and the US presidential elections later in the year may be impactful in this regard. 

Discrete years' performance (%) to previous quarter-end:

 

Dec-23

Dec-22

Dec-21

Dec-20

Dec-19

Liontrust China C Acc GBP

-22.2%

-15.5%

-16.7%

26.5%

17.0%

MSCI China

-16.2%

-12.1%

-21.0%

25.5%

18.7%

IA China/Greater China

-20.2%

-16.0%

-10.7%

33.5%

22.2%

Quartile

3

2

3

3

4


*
Source: FE Analytics, as at 31.12.23, primary share class, total return, net of fees and income reinvested.

Understand common financial words and terms See our glossary
KEY RISKS

Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Overseas investments may carry a higher currency risk. They are valued by reference to their local currency which may move up or down when compared to the currency of the Fund. This Fund may have a concentrated portfolio. If one of these investments or sectors / factors fall in value this can have a greater impact on the Fund's value than if it held a larger number of investments across a more diversified portfolio. The Fund may encounter liquidity constraints from time to time. The spread between the price you buy and sell shares will reflect the less liquid nature of the underlying holdings. Investments in emerging markets may involve a higher element of risk due to less well-regulated markets and political and economic instability. This may result in higher volatility and larger drops in the value of the fund over the short term. Outside of normal conditions, the Fund may hold higher levels of cash which may be deposited with several credit counterparties (e.g. international banks). A credit risk arises should one or more of these counterparties be unable to return the deposited cash. Counterparty Risk: any derivative contract, including FX hedging, may be at risk if the counterparty fails. ESG Risk: In reference to any component (where applicable) of a fund's investment process that uses external ESG data, there may be limitations to the availability, completeness or accuracy of ESG information from third-party providers, or inconsistencies in the consideration of ESG factors across different third party data providers, given the evolving nature of ESG.

DISCLAIMER

This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.

This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust.

Related commentaries

See all related
Fund updates
Liontrust China Fund Q4 2023 review
icon 23 January 2024
Commentaries Global Equity
Fund updates
Liontrust China Fund Q3 2023 review
icon 17 November 2023
Commentaries Global Equity
Fund updates
Liontrust China Fund Q2 2023 review
icon 26 July 2023
Commentaries Global Equity
Fund updates
Liontrust China Fund Q1 2023 review
icon 25 April 2023
Global Equity
Fund updates
Liontrust China Fund Q4 2022 review
icon 30 January 2023
Commentaries Global Equity
Fund updates
Liontrust China Fund Q3 2022 review
icon 24 October 2022
Commentaries Global Equity

Register your preferences and receive tailored communications from Liontrust